Track topics on Twitter Track topics that are important to you
Genmab is a leading international biotechnology company that aims to improve the lives of patients by creating and developing innovative antibody products. The company was founded in Copenhagen, Denmark in 1999 and is publicly traded on the NASDAQ OMX Copenhagen. Genmab employs approximately 180 people with its headquarters and clinical development team in Denmark, research and development laboratories in The Netherlands and administrative functions in the United States.The company’s first marketed antibody, ofatumumab (Arzerra®), was approved to treat chronic lymphocytic leukemia in patients who are refractory to fludarabine and alemtuzumab. Ofatumumab is marketed under a co-development and collaboration agreement with GlaxoSmithKline and has been launched in 24 countries, as of September 2012. In addition to ofatumumab, Genmab is building a deep pipeline of clinical and pre-clinical antibody products to treat cancer and for other diseases where there is an unmet medical need.Genmab uses both validated and next generation proprietary antibody technologies to provide the company with a steady stream of fully human antibody product candidates. These innovative product candidates, as well as the technologies themselves, are a key focus of Genmab’s strategy and interest in them has enabled the company to form alliances with top tier pharmaceutical and biotechnology companies.
Bredgade 23A, 3rd floor
Phone: +45 7020 2728
Fax: +45 70 20 27 49
Genmab A/S has published its Articles of Association dated November 14, 2017. The Articles of Association can be found on Genmab's website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis ...
Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a great example for other European biotechs to follow. Genmab has officially joined the elite of the biotech world ...
Media Release -- Over 25 abstracts on Genmab partnered programs scheduled for presentation at ASH -- Daratumumab: 6 oral presentations; Total of over 20 abstracts accepted including ISSCopenhagen, ...
Media ReleaseCopenhagen, Denmark; September 5, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will give a company update at the Morgan Stanley 15...
Media ReleaseCopenhagen, Denmark; November 7, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company's CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies 20...
Company AnnouncementCopenhagen, Denmark; November 3, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announces its financial calendar for 2018 as follows: EVENT DATE ------------------------------------...
Company Announcement -- Major shareholder announcement for Genmab A/SCopenhagen, Denmark; November 9, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danis...
Company AnnouncementCopenhagen, Denmark; November 14, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 22,532 shares as a consequence of the exercise of employee warran...
Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat c...
Genmab is a leading international biotechnology company that aims to improve the lives of patients by creating and developing innovative antibody products. The company was founded in Copenhagen, Den...
TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...
We have published hundreds of Genmab A/S news stories on BioPortfolio along with dozens of Genmab A/S Clinical Trials and PubMed Articles about Genmab A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genmab A/S Companies in our database. You can also find out about relevant Genmab A/S Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...